Clinical trials hoping to identify a vaginal microbicide that is safe and effective against HIV have all but skirted questions befitting evaluation of an approach intended primarily for sexually active women of childbearing age: What if a woman gets pregnant while using a product?

Can exposure during pregnancy pose a risk to the fetus? Researchers will begin addressing these and other questions in the first clinical trial of a candidate vaginal microbicide in pregnant women.